Dementia and clinical studies

Dementia is an umbrella term for a group of conditions that affect memory, thinking, communication, and everyday functioning. Alzheimer’s disease is the most common form of dementia, but there are several other types, including Dementia with Lewy Bodies and Parkinson’s disease dementia. As people are living longer, the number of individuals affected by dementia is increasing worldwide. At the same time, research in this field is advancing rapidly.

We are continously gaining new insights into what happens in the brain long before symptoms appear, creating opportunities for earlier diagnosis and more effective treatment.

At Neuro-SysMed, we are committed to improving our understanding of dementia and developing better ways to diagnose, treat, and ultimately prevent these diseases. Through a range of clinical studies and research projects, we aim to translate scientific discoveries into real benefits for patients and their families.

Our dementia research aims to:

improve our understanding of why different types of dementia develop
identify biological markers (biomarkers) that can help detect disease at an earlier stage
develop more precise and personalized approaches to diagnosis and treatment
evaluate promising new therapies through clinical studies
support earlier intervention, when treatments may have the greatest impact
contribute to better quality of life for people living with dementia and their families

By bringing together clinical expertise, innovative research, and close collaboration with patients, we hope to accelerate the development of tomorrow’s dementia treatments and improve care for future generations.

Neuro-SysMed currently runs the following clinical studies on dementia:

Last updated 7/3/2026